chevron_leftBack
As of 24 April 2025, Ajanta Pharma Ltd. has a market cap of $3.93B USD, ranking #3405 globally and #239 in India. It ranks #291 in the Healthcare sector, and #49 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$3.93BUSD
334.99B INR
Enterprise Value
$3.84BUSD
327.9B INR
Revenue (TTM)
$531.08MUSD
45.32B INR
EBITDA (TTM)
$145.64MUSD
12.45B INR
Net Income (TTM)
$105.22MUSD
8.98B INR
EBITDA Margin
27%
Profit Margin
20%
PE Ratio
37.5
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.3% | 2% | -1% | -6.1% | -9.8% | 28% |
Upcoming Earnings
Earnings Date
Fri, May 2
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
AJANTPHARM
Ajanta Pharma Ltd
ISIN: INE031B01049
Shares Out.:
Shares Outstanding:
124.912M1
Shares Float:
42.025M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.69K INR | |
|
532331
(AJANTPHARM)
Ajanta Pharma Ltd
ISIN: INE031B01049
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.68K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Ajanta Pharma Ltd.
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
